- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CCNE1 amplification
Total 286 results
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
Rotman Research Institute at BaycrestCompleted
-
Black Diamond Therapeutics, Inc.TerminatedSolid TumorUnited States, Denmark, France, Spain
-
Children's Hospital of Fudan UniversityWithdrawn
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Calithera Biosciences, IncCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditionsUnited States
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Samsung Medical CenterActive, not recruitingAdvanced, Refractory CancerKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedSolid TumorKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
University of Maryland, College ParkWithdrawnAuditory Perceptual Disorders | Age-related Hearing Loss
-
Taipei Medical University WanFang HospitalBuddhist Tzu Chi General Hospital; Taichung Veterans General Hospital; Chang-Hua... and other collaboratorsActive, not recruitingPulmonary Tuberculosis Confirmation by CultureTaiwan
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
Charles TaylorLaureate Institute for Brain Research, Inc.SuspendedSubstance-Related Disorders | Depression | Alcohol Drinking | Drinking Behavior | Alcoholism | Alcohol-Related Disorders | Anxiety | Mental DisorderUnited States
-
Sameek RoychowdhuryNational Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ALK Gene Mutation | Metastatic Malignant Neoplasm in the Brain | Advanced Malignant Neoplasm | ALK Fusion Protein Expression | Metastatic Malignant Neoplasm in the Central Nervous System | ROS1 Gene Mutation | ALK Gene... and other conditionsUnited States
-
Medical College of WisconsinUniversity of Wisconsin, MilwaukeeCompleted
-
Massachusetts Eye and Ear InfirmaryCompletedUnilateral Hearing LossUnited States
-
Washington University School of MedicineCompletedDiarrhea | Clostridium Difficile InfectionUnited States
-
Grupo Español de Investigación en NeurooncologíaPfizerCompleted
-
Spectrum Pharmaceuticals, IncTerminated
-
San Diego State UniversityUniversity of California, San DiegoWithdrawn
-
Loma Linda UniversityWithdrawnKnee Arthroscopy | Arthritis of Knee | Normal Knee
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR1 Gene Mutation | FGFR3 Gene AmplificationUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
University of California, DavisBioFire Diagnostics, LLCCompletedRespiratory Tract Infections | Influenza, Human | Common ColdUnited States
-
Novartis PharmaceuticalsTerminatedCeritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (SIGNATURE)Tumors With Aberrations in ALK or ROS1United States
-
UNICANCERTerminated
-
Hunter College of City University of New YorkUniversidad Autonoma Juan Misael Saracho; Gobierno Autonomo Departamental De... and other collaboratorsCompleted
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
University Hospital, BordeauxUnknown
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
University Hospital TuebingenUniversity Hospital of CologneCompletedAntibiotic Selection PressureGermany
-
Arog Pharmaceuticals, Inc.CompletedRecurrent/Refractory GlioblastomaUnited States
-
University of AarhusOdense University Hospital; Rigshospitalet, Denmark; Herlev Hospital; Vejle Hospital and other collaboratorsCompleted
-
NYU Langone HealthWithdrawnCochlear Hearing Loss | Cochlear ImplantUnited States
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
Arog Pharmaceuticals, Inc.AvailableFLT3-ITD Mutation | FLT3/TKD Mutation | PDGFR-Alpha D842V | PDGFRA Gene AmplificationItaly
-
Beijing Ditan HospitalUnknown
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Asan Medical CenterNovartisCompleted
-
Jin-Hee AhnAsan Medical CenterUnknownHER-2 Gene Amplification | HER-2 Protein Overexpression
-
Assiut UniversityUnknownMultiple Myeloma
-
Samsung Medical CenterCompleted